Semaglutide, a GLP-1 receptor agonist, has changed weight management for millions, but combining it with antibiotics raises important safety questions
(148) noted in their 2023 systematic review that the prevalence of HHcy in ESRD patients is approximately 85%100%, significantly increasing cardiovascular event risk
Ude C, Schubert-Zsilavecz M, Wurglics M (2013) Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients
This could negatively affect glycemic control and predispose people with diabetes to more complications
Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers
Neurological disorders, such as numbness of the limbs and tingling feelings have been reported, as well as psychological symptoms, generally seen through mood disorders